Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: A population-based case-control study

Montserrat Garcia-Closas, Louise A. Brinton, Jolanta Lissowska, Douglas Richesson, Mark E. Sherman, Neonila Szeszenia-Dabrowska, Beata Peplonska, Robert Welch, Meredith Yeager, Witold Zatonski, Stephen J. Chanock

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: The sex hormone-binding globulin (SHBG) is a carrier protein that modulates the bio-availability of serum sex steroid hormones, which may be involved in ovarian cancer. We evaluated whether common genetic variation in SHBG and its 3′ neighbor ATP1B2, in linkage disequilibrium, is associated with the risk of epithelial ovarian cancer. Methods: The study population included 264 women with ovarian carcinoma and 625 controls participating in a population-based case-control study in Poland. Five common single nucleotide polymorphisms (SNPs) in SHGB and five in ATP1B2 were selected to capture most common variation in this region. Results: None of the SNPs evaluated was significantly associated with ovarian cancer risk, including the putative functional SNPs SHBG D356N (rs6259) and -67G>A 5′UTR (rs1799941). However, our data were consistent with a decreased ovarian cancer risk associated with the variant alleles for these two SNPs, which have been previously associated with increased circulating levels of SHBG. Conclusion: These data do not support a substantial association between common genetic variation in SHBG and ovarian cancer risk.

Original languageEnglish (US)
Article number60
JournalBMC Cancer
Volume7
DOIs
StatePublished - Apr 5 2007

Fingerprint

Sex Hormone-Binding Globulin
Ovarian Neoplasms
Case-Control Studies
Single Nucleotide Polymorphism
Population
Genes
Linkage Disequilibrium
Gonadal Steroid Hormones
Poland
Carrier Proteins
Alleles
Carcinoma
Serum

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Garcia-Closas, M., Brinton, L. A., Lissowska, J., Richesson, D., Sherman, M. E., Szeszenia-Dabrowska, N., ... Chanock, S. J. (2007). Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: A population-based case-control study. BMC Cancer, 7, [60]. https://doi.org/10.1186/1471-2407-7-60

Ovarian cancer risk and common variation in the sex hormone-binding globulin gene : A population-based case-control study. / Garcia-Closas, Montserrat; Brinton, Louise A.; Lissowska, Jolanta; Richesson, Douglas; Sherman, Mark E.; Szeszenia-Dabrowska, Neonila; Peplonska, Beata; Welch, Robert; Yeager, Meredith; Zatonski, Witold; Chanock, Stephen J.

In: BMC Cancer, Vol. 7, 60, 05.04.2007.

Research output: Contribution to journalArticle

Garcia-Closas, M, Brinton, LA, Lissowska, J, Richesson, D, Sherman, ME, Szeszenia-Dabrowska, N, Peplonska, B, Welch, R, Yeager, M, Zatonski, W & Chanock, SJ 2007, 'Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: A population-based case-control study', BMC Cancer, vol. 7, 60. https://doi.org/10.1186/1471-2407-7-60
Garcia-Closas, Montserrat ; Brinton, Louise A. ; Lissowska, Jolanta ; Richesson, Douglas ; Sherman, Mark E. ; Szeszenia-Dabrowska, Neonila ; Peplonska, Beata ; Welch, Robert ; Yeager, Meredith ; Zatonski, Witold ; Chanock, Stephen J. / Ovarian cancer risk and common variation in the sex hormone-binding globulin gene : A population-based case-control study. In: BMC Cancer. 2007 ; Vol. 7.
@article{fba00aecd0834da6b42237c90aca41d5,
title = "Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: A population-based case-control study",
abstract = "Background: The sex hormone-binding globulin (SHBG) is a carrier protein that modulates the bio-availability of serum sex steroid hormones, which may be involved in ovarian cancer. We evaluated whether common genetic variation in SHBG and its 3′ neighbor ATP1B2, in linkage disequilibrium, is associated with the risk of epithelial ovarian cancer. Methods: The study population included 264 women with ovarian carcinoma and 625 controls participating in a population-based case-control study in Poland. Five common single nucleotide polymorphisms (SNPs) in SHGB and five in ATP1B2 were selected to capture most common variation in this region. Results: None of the SNPs evaluated was significantly associated with ovarian cancer risk, including the putative functional SNPs SHBG D356N (rs6259) and -67G>A 5′UTR (rs1799941). However, our data were consistent with a decreased ovarian cancer risk associated with the variant alleles for these two SNPs, which have been previously associated with increased circulating levels of SHBG. Conclusion: These data do not support a substantial association between common genetic variation in SHBG and ovarian cancer risk.",
author = "Montserrat Garcia-Closas and Brinton, {Louise A.} and Jolanta Lissowska and Douglas Richesson and Sherman, {Mark E.} and Neonila Szeszenia-Dabrowska and Beata Peplonska and Robert Welch and Meredith Yeager and Witold Zatonski and Chanock, {Stephen J.}",
year = "2007",
month = "4",
day = "5",
doi = "10.1186/1471-2407-7-60",
language = "English (US)",
volume = "7",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Ovarian cancer risk and common variation in the sex hormone-binding globulin gene

T2 - A population-based case-control study

AU - Garcia-Closas, Montserrat

AU - Brinton, Louise A.

AU - Lissowska, Jolanta

AU - Richesson, Douglas

AU - Sherman, Mark E.

AU - Szeszenia-Dabrowska, Neonila

AU - Peplonska, Beata

AU - Welch, Robert

AU - Yeager, Meredith

AU - Zatonski, Witold

AU - Chanock, Stephen J.

PY - 2007/4/5

Y1 - 2007/4/5

N2 - Background: The sex hormone-binding globulin (SHBG) is a carrier protein that modulates the bio-availability of serum sex steroid hormones, which may be involved in ovarian cancer. We evaluated whether common genetic variation in SHBG and its 3′ neighbor ATP1B2, in linkage disequilibrium, is associated with the risk of epithelial ovarian cancer. Methods: The study population included 264 women with ovarian carcinoma and 625 controls participating in a population-based case-control study in Poland. Five common single nucleotide polymorphisms (SNPs) in SHGB and five in ATP1B2 were selected to capture most common variation in this region. Results: None of the SNPs evaluated was significantly associated with ovarian cancer risk, including the putative functional SNPs SHBG D356N (rs6259) and -67G>A 5′UTR (rs1799941). However, our data were consistent with a decreased ovarian cancer risk associated with the variant alleles for these two SNPs, which have been previously associated with increased circulating levels of SHBG. Conclusion: These data do not support a substantial association between common genetic variation in SHBG and ovarian cancer risk.

AB - Background: The sex hormone-binding globulin (SHBG) is a carrier protein that modulates the bio-availability of serum sex steroid hormones, which may be involved in ovarian cancer. We evaluated whether common genetic variation in SHBG and its 3′ neighbor ATP1B2, in linkage disequilibrium, is associated with the risk of epithelial ovarian cancer. Methods: The study population included 264 women with ovarian carcinoma and 625 controls participating in a population-based case-control study in Poland. Five common single nucleotide polymorphisms (SNPs) in SHGB and five in ATP1B2 were selected to capture most common variation in this region. Results: None of the SNPs evaluated was significantly associated with ovarian cancer risk, including the putative functional SNPs SHBG D356N (rs6259) and -67G>A 5′UTR (rs1799941). However, our data were consistent with a decreased ovarian cancer risk associated with the variant alleles for these two SNPs, which have been previously associated with increased circulating levels of SHBG. Conclusion: These data do not support a substantial association between common genetic variation in SHBG and ovarian cancer risk.

UR - http://www.scopus.com/inward/record.url?scp=34247623076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247623076&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-7-60

DO - 10.1186/1471-2407-7-60

M3 - Article

C2 - 17411440

AN - SCOPUS:34247623076

VL - 7

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 60

ER -